94 results
Page 2 of 5
8-K
EX-99.1
vfvnfi n0zwkgymru
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
EX-1.1
to8pnr3qbj3n2rt5yb0
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
8-K
EX-99.2
rqoh45k4lqq1 srgq
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
o0s5i yjde2ygy1
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
1sz 0u4815k
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
zht2e
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
EX-99.1
8brv4rnehsofnwh6
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
EX-99.2
z8v9dc2qvf
12 Nov 21
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
7:21am
8-K
EX-99.2
v3dm5 lmpwrke
12 Aug 21
Larimar Therapeutics Reports Second Quarter 2021 Operating and Financial Results
10:29am
8-K
EX-99.1
hd2i8m9y73dp2yawmv
1 Jul 21
Other Events
6:11am
8-K
EX-99.1
f9j87rub
14 Jun 21
Other Events
5:21pm
8-K
EX-4.1
fuyp3rdotm svt
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.1
ds8rs9fv
21 May 21
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.1
2x5qmzi
18 May 21
Other Events
3:09pm
8-K
EX-99.1
ya13qa tvz
8 Dec 20
Regulation FD Disclosure
7:40am
8-K
EX-99.2
l3aotst
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm